Vijayalaksmi Arumugam

Statistics

Publications

Citations

1.4K

H-Index

Active since

1997

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Vijayalaksmi Arumugam is an author at Vertex Pharmaceuticals (United States) specializing in pharmacology, molecular pharmacology, and medicinal chemistry.

Publications per year

1997–2014

Publications

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

Fredrick Van Goor, Sabine Hadidaꝉ, Peter D. J. Grootenhuis et al. · Proceedings of the National Academy of Sciences · 2009 · 1.2K citations · Full text

Medicine, Cell Biology, Pharmacology +17

Discovery of <i>N</i>-(2,4-Di-<i>tert</i>-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, Ivacaftor), a Potent and Orally Bioavailable CFTR Potentiator

Sabine Hadidaꝉ, Fredrick Van Goor, Jinglan Zhou et al. · Journal of Medicinal Chemistry · 2014 · 114 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Synthesis of 2-Oxindole Derivatives via the Intramolecular Heck Reaction on Solid Support

Vijayalaksmi Arumugam, Anne Routledge, Chris Abell et al. · Tetrahedron Letters · 1997 · 77 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9

1–3 of 3